By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Corporate Headquarters
One Amgen Center Drive
Thousand Oaks  California  91320-1789  U.S.A.
Phone: 805-447-1000 Fax: 805-447-1010


Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

For more information, visit and follow us on

Key Statistics

Ownership: Public

Web Site: Amgen
Employees: 7,300+ Worldwide
Symbol: AMGN


Genesis Research and Development Corporation 

Phylos, Inc.  In 2000, Phylos entered into collaboration with Amgen to apply Phylos' PROfusion™ technology to rapidly identify high-affinity binding agents to potential therapeutic targets supplied by Amgen. Amgen will use the sequences and structural information gained through this collaboration for its internal drug discovery programs.

UCB, Inc.  Contract manufacturing of Abarelix peptide active ingredient

EPIX Pharmaceuticals, Inc. 

Dyax  Antibody phage display

Company News
XBiotech USA (XBIT) Appoints Amgen (AMGN) Veteran Scott Whitehurst As Chief Financial Officer 5/3/2016 7:50:45 AM
Amgen (AMGN)'s First Quarter 2016 Revenues Increased 10 Percent To $5.5 Billion And Adjusted Earnings Per Share (EPS) Increased 17 Percent To $2.90 4/29/2016 6:33:53 AM
Amgen (AMGN) Announces Webcast Of 2016 First Quarter Financial Results 4/26/2016 7:53:06 AM
Crystal Ball Gazing: Amgen (AMGN)’s Q1 Financials, What to Look For 4/26/2016 7:09:46 AM
Amgen (AMGN) To Participate In The 2016 World Medical Innovation Forum On Cancer 4/25/2016 8:37:49 AM
20 Reasons To Buy Amgen (AMGN) And Never Sell 4/21/2016 7:23:43 AM
Amgen (AMGN) Release: Nplate (Romiplostim) Study In The Lancet Shows Significant Increase In Durable Platelet Response Among Children With Immune Thrombocytopenia 4/20/2016 6:23:35 AM
California Life Sciences Institute (CLSI) Names Winner Of Amgen (AMGN) Bay Area BioGENEius Competition 4/18/2016 10:36:59 AM
KGI Announces Robert A. Bradway, Chairman And Chief Executive Officer At Amgen (AMGN) As Keynote Speaker For Its 15th Annual Commencement Ceremony 4/15/2016 8:59:02 AM
Flatiron Health Announces Strategic Relationships With Celgene (CELG) And Amgen (AMGN) To Further Advance Personalized Medicine For Cancer Patients And Accelerate Clinical Research 4/8/2016 12:09:10 PM